134 related articles for article (PubMed ID: 34285167)
1. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
6. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and microbiological profile of viridans group streptococci bacteremia in children with cancer and high-risk febrile neutropenia].
Cortés D; Maldonado ME; Rivacoba MC; Maza V; Valenzuela R; Payá E; Contardo V; Álvarez AM; Avilés CL; Becker A; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
Rev Chilena Infectol; 2020 Aug; 37(4):383-388. PubMed ID: 33399658
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
9. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
BMC Infect Dis; 2013 Jun; 13():273. PubMed ID: 23773209
[TBL] [Abstract][Full Text] [Related]
11. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
Bruckner L; Gigliotti F
Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
[TBL] [Abstract][Full Text] [Related]
12. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W
Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream infection by multidrug-resistant Streptococcus oralis in a leukemic patient with febrile neutropenia after hematopoietic stem cell transplantation.
Watanabe N; Kobayashi K; Koyama S; Tabira M; Matsuno J; Taji Y; Akuzawa Y; Ishikawa M; Maeda T; Imai K; Tarumoto N; Asou N; Mitsutake K; Ebihara Y
Transpl Infect Dis; 2020 Apr; 22(2):e13246. PubMed ID: 31943573
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
Shargian L; Paul M; Nachshon T; Ayada G; Nesher L; Raanani P; Ben-Zvi H; Henig O; Yahav D
Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):177-182. PubMed ID: 36502498
[TBL] [Abstract][Full Text] [Related]
15. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.
Jaffe D; Jakubowski A; Sepkowitz K; Sebti R; Kiehn TE; Pamer E; Papanicolaou GA
Clin Infect Dis; 2004 Dec; 39(11):1625-32. PubMed ID: 15578362
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
17. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
[TBL] [Abstract][Full Text] [Related]
18. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review.
Danilatou V; Mantadakis E; Galanakis E; Christidou A; Stiakaki E; Kalmanti M
Scand J Infect Dis; 2003; 35(11-12):873-6. PubMed ID: 14723365
[TBL] [Abstract][Full Text] [Related]
19. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]